Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.

Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.

Item
http://www.wikidata.org/entity/Q34118325
Nanobacteria are mineralo fetuin complexesPepper mild mottle virus, a plant virus associated with specific immune responses, Fever, abdominal pains, and pruritus in humansImmunogenicity of self-associated aggregates and chemically cross-linked conjugates of the 42 kDa Plasmodium falciparum merozoite surface protein-1Revised Mimivirus major capsid protein sequence reveals intron-containing gene structure and extra domainMicroarray for serotyping of Bartonella species.Plasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.Optimal seasonal timing of oral azithromycin for malaria.CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccineLong-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.Vaccination with novel immunostimulatory adjuvants against blood-stage malaria in mice.Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen.Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome.Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders.Improving vaccines by incorporating immunological coadjuvants.TLR9 adjuvants enhance immunogenicity and protective efficacy of the SE36/AHG malaria vaccine in nonhuman primate models.Immunogenicity and in vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum.Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.
P2860

Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.

Item
http://www.wikidata.org/entity/Q34118325
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Improved immunogenicity and ef ...... murine malaria vaccine model.
@ast
Improved immunogenicity and ef ...... murine malaria vaccine model.
@en
Improved immunogenicity and ef ...... murine malaria vaccine model.
@nl
type
label
Improved immunogenicity and ef ...... murine malaria vaccine model.
@ast
Improved immunogenicity and ef ...... murine malaria vaccine model.
@en
Improved immunogenicity and ef ...... murine malaria vaccine model.
@nl
prefLabel
Improved immunogenicity and ef ...... murine malaria vaccine model.
@ast
Improved immunogenicity and ef ...... murine malaria vaccine model.
@en
Improved immunogenicity and ef ...... murine malaria vaccine model.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Improved immunogenicity and ef ...... murine malaria vaccine model.
@en
P2093
P2860
P304
P31
P356
10.1128/IAI.70.2.692-701.2002
P407
P433
P478
P577
P698
P921
P932